Status:
NOT_YET_RECRUITING
Hybrid Interactive Avatars for Post-COVID Sufferers
Lead Sponsor:
University Hospital of Cologne
Collaborating Sponsors:
University of Applied Sciences Cologne
Humanizing Technologies GmbH
Conditions:
Post-Acute COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate an app to improve communication and information flows for persons suffering from Post-COVID-19 syndrome (PCS). The main questions it aims to answer ...
Detailed Description
The overarching goal of the HINT project is to develop an app that people affected by PCS can use on their own devices in a language of their choice (e.g. their native language) to increase their heal...
Eligibility Criteria
Inclusion
- Existence of a declaration of consent
- Stable clinical condition
- Diagnosis of Post-COVID syndrome according to the World Health Organization (WHO):
- Symptoms persist for more than 12 weeks
- Duration: at least 2 months
- Etiology: no alternative diagnosis
- Progression: persistent, recurrent, fluctuating
Exclusion
- Known psychiatric or somatic illness that can explain the symptoms
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06218849
Start Date
January 1 2024
End Date
December 1 2025
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Cologne
Cologne, Northrhine-Westfalia, Germany, 50937